SCHEMBL7679073

SCHEMBL7679073

CN(C)CCCNCc1ccnc(N2CCOCC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
SLC40A1 Q9NP59 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
PIK3CA P42336 2/20 0.41
MAPK14 Q16539 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRL1 P41146 1/20 0.41
MKNK1 Q9BUB5 1/20 0.40
TERT O14746 2/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
PIK3CB P42338 1/20 0.40
OGA O60502 1/20 0.39
SYK P43405 1/20 0.38
SLC8A1 P32418 1/20 0.38
KLKB1 P03952 2/20 0.38
KLK1 P06870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677919 0.83 CYP2C19 (0.67) CYP3A4CYP2D6CYP2C19SLC40A1GAA
SCHEMBL7682114 0.81 CYP2C19 (0.60) CYP3A4CYP2D6CYP2C19SLC40A1PIK3CA
SCHEMBL7681152 0.81 CYP2D6 (0.55) CYP3A4CYP2D6CYP2C19SLC40A1KDM4E
SCHEMBL10154083 0.79 PIK3CA (0.50) CYP3A4CYP2C19KDM4EPIK3CAOPRM1
SCHEMBL7679598 0.76 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C19SLC40A1KDM4E
SCHEMBL10210050 0.76 PIK3CA (0.50) KDM4EPIK3CACDK2PIK3CBOGA
SCHEMBL24455071 0.75 RAB9A (0.53) CYP2C19KDM4EGAAPIK3CAPIK3CB
SCHEMBL29561895 0.75 RAB9A (0.53) CYP2C19KDM4EGAAPIK3CAPIK3CB
SCHEMBL8197483 0.74 PIK3CA (0.59) CYP2C19PIK3CAOPRM1OPRL1PIK3CB
SCHEMBL8228263 0.73 LRRK2 (0.56) CYP2C19PIK3CAOPRM1OPRL1PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 US disclosed